20LA Pill - white round, 12mm
Generic Name: lamotrigine
Pill with imprint 20LA is White, Round and has been identified as Subvenite 200 mg. It is supplied by OWP Pharmaceuticals, Inc.
Subvenite is used in the treatment of Bipolar Disorder; Epilepsy; Lennox-Gastaut Syndrome; Seizure Prevention. Risk cannot be ruled out during pregnancy. Subvenite 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 20LA
Subvenite
- Generic Name
- lamotrigine
- Imprint
- 20LA
- Strength
- 200 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Round
- Availability
- Prescription only
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- OWP Pharmaceuticals, Inc.
- Manufacturer
- Torrent Pharmaceuticals Limited
- National Drug Code (NDC)
- 69102-0320
More about Subvenite (lamotrigine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Latest FDA alerts (6)
- Side effects
- Dosage information
- During pregnancy or Breastfeeding
- En español
Patient resources
Other brands
Lamictal, Lamictal XR, Lamictal CD, Lamictal ODT
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.